GLP-1 medications work by mimicking the incretin hormone glucagon-like peptide-1, which enhances insulin secretion in response to food, suppresses glucagon release, slows gastric emptying, and reduces appetite
Considering the unique nature of glucose-dependent insulin secretion in response to incretin hormones, it would be timely to review the pancreatic -cell response to glucose and incretin hormones and how it is modulated by current anti-diabetic medications
[4] Cause 2: Neurogenic Origin Although we have a basic understanding of how GLP-1 drugs work on blood sugar and appetite, we still dont fully understand why they cause nausea
The findings of our study have significant implications for the management of metabolic obesity in adolescents
Studies have shown that IGF-1 LR3 has a prolonged half-life, enhancing its effectiveness in promoting muscle growth, cell proliferation, and fat metabolism
Patients lose weight, blood sugars normalize, cardiovascular risk drops, and Im particularly impressed by what these medications appear to do in the brains of patients with addiction in their lives